Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Brainstorm Cell Therapeutics Inc

+ Add to Watchlist

BCLI:US

3.9400 USD 0.0300 0.77%

As of 20:10:00 ET on 05/27/2015.

Snapshot for Brainstorm Cell Therapeutics Inc (BCLI)

Open: 3.9500 Day's Range: 3.8600 - 4.0200 Volume: 171,183
Previous Close: 3.9100 52wk Range: 2.8100 - 8.4667 1-Yr Rtn: +3.82%

Stock Chart for BCLI

No chart data available.
  • BCLI:US 3.9400
  • 1D
  • 1M
  • 1Y
3.9100
Interactive BCLI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BCLI

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4700
Est. EPS (USD) (12/2015) -0.5700
Est. PEG Ratio -
Market Cap (M USD) 72.81
Shares Outstanding (M) 18.48
30 Day Average Volume 348,093
Price/Book (mrq) 9.0201
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BCLI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BCLI

Brainstorm Cell Therapeutics Inc is a biotechnology company developing autologous adult stem cell therapies for neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS) , also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD).

Anthony Fiorino "Tony"Chief Executive OfficerChaim LebovitsPresident
Liat SossoverChief Financial OfficerUri YablonkaChief Operating Officer
More Company Profile & Key Executives for BCLI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil